DR Horton Inc (DHI · NYSE)

DHI · MARKET VIEW

Market view · as of Oct 12, 2026

Revenue (TTM)
$33.35B
0.0% YoY
Gross margin
21.3%
EPS (latest q)
$3.20
vs $2.99 est · beat
52-wk position
9.0%
-19.1% vs 52w high · -2.2% 1mo

Price (last ~year)

D.R. Horton (DHI, NYSE) trades at $134.88, down 12.4% over three months and 19.1% below its 52-week high, with the stock sitting just 9% above its 52-week low. The company beat estimates in three of its last four quarters, most recently reporting $3.20 versus $2.99 expected, though earnings fell 4.8% year over year on flat revenue (TTM $33.35B). Balance sheet strength remains a feature: a 9.84 current ratio, $2.08B in cash, and debt/EBITDA of 1.7x, with quarterly FCF of $374.7M in the June quarter. Valuation is modest at a 12.94 P/E and 1.648 P/B, while the analyst target of $155 sits well above the current price.

Valuation

Market cap
$37.73B
P/E
12.94
PEG
1.179
P/B
1.648
P/S
1.131
EV/EBITDA
11.31
Beta
1.351
Analyst target
$155

Quality & returns

Gross margin
21.3%
Operating margin
13.0%
Profit margin
9.2%
ROE
12.6%
ROA
6.9%

Price movement

Last
$134.88
1-month
-2.2%
3-month
-12.4%
RSI (14)
43
vs SMA200
-8.6%
52-wk position
9.0% -19.1% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$9.23B$1.23B$904.9M$1.26B
2026-03-31$7.56B$800.0M$647.9M$760.7M
2025-12-31$6.89B$729.6M$594.8M$857.1M
2025-09-30$9.68B$1.13B$905.3M$1.23B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots